Global Clinical Trials Market (2021-2026) – Leveraging Online Resources to Increase Patient Recruitment Rates in Clinical Trials Presents Opportunities – ResearchAndMarkets.com

DUBLIN – (BUSINESS WIRE)–The “Global Clinical Trials Market (2021-2026) by Study Phases, Study Designs, Indication of Disease, Geography and Impact of COVID-19 with Ansoff Analysis” the report was added to ResearchAndMarkets.com from offer.

The global clinical trials market is estimated at $ 29.35 billion in 2021 and is expected to reach $ 43.75 billion by 2026, with a CAGR of 8.3%.

Clinical trials are scientific studies aimed at understanding how a particular medical approach reciprocates in different groups of people. They are performed to diagnose, detect and prevent various types of diseases. They can be used to assess the effectiveness of new drugs or devices such as catheters, etc. The clinical trials industry is the link between the laboratory / research organization and the new drug market. Thus, the market is constantly evolving with a series of new clinical studies launched at an ever faster pace.

With the increase in demand for new drugs and medical equipment among healthcare providers, the clinical trial markets have been on the rise. However, solutions that are both permanent and effective take considerable time in terms of approval, slowing the growth of the market.

Why buy this report?

  • The report offers a comprehensive assessment of the global clinical trials market.

  • The report includes in-depth qualitative analysis, verifiable data from authentic sources, and market size projections. Projections are calculated using proven research methodologies.

  • The report has been compiled using extensive primary and secondary research. Primary research is done through interviews, surveys and observations of renowned industry personnel.

  • The report includes an in-depth analysis of the market using Porter’s 5 force model and Ansoff matrix. The impact of Covid-19 on the market is also presented in the report.

  • The report also contains competitive analysis using Competitive Quadrant, the analyst’s proprietary competitive positioning tool.

Market dynamics

Conductors

  • Globalization of drug development activities

  • Increase in R&D investments to develop new health products

  • High prevalence of diseases in emerging countries

Constraints

  • Longer approval time

  • Lack of skilled labor in clinical research

Opportunities

  • Leverage online resources to increase patient enrollment rates in clinical trials

  • Growing partnerships between pharmaceutical biotechnology companies and clinical research organizations

Tendencies

  • Applications of activated technological measures

Companies mentioned

  • Aaipharma Services Corp.

  • Accell Clinical Research LLC

  • Aptiv Solutions

  • Chiltern International Limited

  • Congenix

  • Covance Inc.

  • Ecron Acunova Ltd

  • Eurotrials

  • ICON Plc

  • Inc Research LLC

  • Medpace Inc

  • Parexel International Corp

  • Pharmanet Development Group

  • Pharmaceutical Product Development Inc

  • PRA International

  • Quintiles Transnational Corp

  • Siro Clinpharm Pvt. Ltd

  • TCG Lifesciences Ltd

  • Theoretical clinical research

  • Pfizer

  • Novo Nordisk A / S

  • SGS SA

  • IQVIA

For more information on this report, visit https://www.researchandmarkets.com/r/gvyqtz

About William G.

Check Also

Global Primary Antibodies Market 2021 – Industry Overview, Key Trends, Growth and Forecast to 2027 – Stillwater Current

MarketandResearch.biz posted a Global Primary Antibodies Market 2021-2027 Global research report containing market insight, practical …